Inventor · disambiguated record
Gilles Guichard
Also filed as: BRIAND JEAN-PAUL · GUICHARD GILLES · GUICHARD GILLES FRANCOIS ROGER
26 granted patents·11 pending applications·88 citations·filing 1995–2021
94Inventor score
Top patents by PatentIndex Score
37 records- 0184US7741280B2Multimeric molecules, the preparation method thereof and use of same for the preparation of medicamentsCENTRE NAT RECH SCIENT·Filed 2003·Granted Jun 22, 2010·19 cites·17 claims
- 0284US7691807B2Hybrid oligomers, their preparation process and pharmaceutical compositions containing themCENTRE NAT RECH SCIENT·Filed 2006·Granted Apr 6, 2010·7 cites·28 claims
- 0384US7186739B2Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureasIMMUPHARMA FRANCE SA·Filed 2005·Granted Mar 6, 2007·7 cites·5 claims
- 0478US7186828B2Cyclic urea compounds and preparation thereofIMMUPHARMA FRANCE SA·Filed 2001·Granted Mar 6, 2007·13 cites·3 claims
- 0577US7060845B2Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureasCENTRE NAT RECH SCIENT·Filed 2001·Granted Jun 13, 2006·14 cites·13 claims
- 0676US8138145B2Hybrid oligomers, their preparation process and pharmaceutical compositions containing themVIOLETTE AUDE·Filed 2010·Granted Mar 20, 2012·4 cites·9 claims
- 0772US10398750B2Peptide-oligourea chimeric compounds and methods of their useUREKA SARL·Filed 2014·Granted Sep 3, 2019·1 cites·10 claims
- 0872US8497349B2Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammationCOURTY JOSE·Filed 2007·Granted Jul 30, 2013·3 cites·11 claims
- 0970US7872098B1Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologiesCENTRE NAT RECH SCIENT·Filed 2002·Granted Jan 18, 2011·4 cites·5 claims
- 1064US8475800B2Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologiesMULLER SYLVIANE·Filed 2010·Granted Jul 2, 2013·1 cites·8 claims
- 1164US7777030B2Compositions and methods for the treatment and prevention of diseaseCENTRE NAT RECH SCIENT·Filed 2006·Granted Aug 17, 2010·1 cites·7 claims
- 1260US7122193B1Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosisBIOMERIEUX SA·Filed 2000·Granted Oct 17, 2006·1 cites·14 claims
- 1359US10889627B2Pro-drug peptide with improved pharmaceutical propertiesUREKA SARL·Filed 2018·Granted Jan 12, 2021·0 cites·29 claims
- 1459US9133240B2Compounds binding to the bacterial beta ringBURNOUF DOMINIQUE·Filed 2012·Granted Sep 15, 2015·1 cites·16 claims
- 1559US2020155637A1Peptide-oligourea chimeric compounds and methods of their useUREKA SARL·Filed 2019·Application pending·0 cites
- 1657US9254309B2Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammationCENTRE NAT RECH SCIENT·Filed 2013·Granted Feb 9, 2016·0 cites·20 claims
- 1756US11267861B2Peptide-oligourea foldamer compounds and methods of their useUREKA SARL·Filed 2017·Granted Mar 8, 2022·0 cites·10 claims
- 1855US2021122800A1Pro-drug peptide with improved pharmaceutical propertiesUREKA SARL·Filed 2020·Application pending·0 cites
- 1954US2014004136A1Phosphorylated derivatives of a u1-70k peptide and their use in the treatment of autoimmune pathologiesCENTRE NAT RECH SCIENT·Filed 2013·Application pending·0 cites
- 2052US2010047333A1Modified Peptides and Their Use for the Treatment of Autoimmune DiseasesMULLER SYLVIANE·Filed 2009·Application pending·0 cites
- 2150US6455244B1Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agentsBIOMERIEUX SA·Filed 1995·Granted Sep 24, 2002·12 cites·7 claims
- 2250US2023312646A1Antibacterial peptidesCENTRE NAT RECH SCIENT·Filed 2021·Application pending·0 cites
- 2347US2016200783A1Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammationCENTRE NAT RECH SCIENT·Filed 2016·Application pending·0 cites
- 2446US7691899B2Urea oligomers, the preparation method thereof and pharmaceutical composition containing sameCENTRE NAT RECH SCIENT·Filed 2002·Granted Apr 6, 2010·0 cites·16 claims
- 2545US12098217B2Fusion peptides as antimicrobial agentsCENTRE NAT RECH SCIENT·Filed 2020·Granted Sep 24, 2024·0 cites·18 claims
- 2644US11285219B2Peptide-oligourea hybrid compoundsUREKA SARL·Filed 2020·Granted Mar 29, 2022·0 cites·11 claims
- 2744US8071640B2Urea oligomers, their preparation process and pharmaceutical compositions containing themGUICHARD GILLES FRANCOIS ROGER·Filed 2010·Granted Dec 6, 2011·0 cites·13 claims
- 2843US2002076693A1Novel cell surface receptor for HIV retroviruses, therapeutic and diagnostic usesINST PASTEUR AND CT NAT DE LA·Filed 2001·Application pending·0 cites
- 2942US2019142905A1Peptide-oligourea foldamer compounds and methods of their useUREKA SARL·Filed 2018·Application pending·0 cites
- 3039US9243030B2Optically pure compounds for improved therapeutic efficiencyBRIAND JEAN PAUL·Filed 2008·Granted Jan 26, 2016·0 cites·22 claims
- 3135US2010291199A1Compositions and Methods For The Treatment and Prevention of DiseaseCENTRE NAT RECH SCIENT·Filed 2010·Application pending·0 cites
- 3235US2010136034A1Novel multimeric molecules, a process for preparing the same and the use thereof for manufacturing medicinal drugsCENTRE NAT RECH SCIENT·Filed 2008·Application pending·0 cites
- 3331US10414722B2Bioinspired catalysis using oligourea helical foldamersCENTRE NAT RECH SCIENT·Filed 2016·Granted Sep 17, 2019·0 cites·21 claims
- 3431US8357654B2Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugsCENTRE NAT RECH SCIENT·Filed 2005·Granted Jan 22, 2013·0 cites·13 claims
- 3525US10233213B2Foldamer helix bundle-based molecular encapsulationUREKA SARL·Filed 2016·Granted Mar 19, 2019·0 cites·24 claims
- 3625US9040513B2Process for preparing platinum-carbene complexesBELLEMIN-LAPONNAZ STÉPHANE·Filed 2011·Granted May 26, 2015·0 cites·20 claims
- 3723US2014057887A1Novel platinum-carbene complexes and use thereof as medicamentsBELLEMIN-LAPONNAZ STEPHANE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →